Share on StockTwits

Endo International PLC (NASDAQ:ENDP) will announce its Q214 earnings results on Thursday, July 31st. Analysts expect the company to announce earnings of $0.88 per share and revenue of $644.60 million for the quarter. Endo International PLC has set its FY14 guidance at $3.60-3.85 EPS.Parties interested in registering for the company’s conference call can do so using this link.

Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.08. The company had revenue of $595.00 million for the quarter, compared to the consensus estimate of $608.86 million. During the same quarter in the previous year, the company posted $1.09 earnings per share. The company’s revenue for the quarter was down 9.3% on a year-over-year basis. On average, analysts expect Endo International PLC to post $3.74 EPS for the current fiscal year and $4.13 EPS for the next fiscal year.

Endo International PLC (NASDAQ:ENDP) opened at 66.66 on Wednesday. Endo International PLC has a 1-year low of $36.17 and a 1-year high of $82.16. The stock has a 50-day moving average of $68.47 and a 200-day moving average of $68.77. The company’s market cap is $10.150 billion.

ENDP has been the subject of a number of recent research reports. Analysts at Deutsche Bank initiated coverage on shares of Endo International PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $81.00 price target on the stock. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Tuesday, July 15th. They now have a $71.00 price target on the stock. Finally, analysts at Goldman Sachs upgraded shares of Endo International PLC from a “buy” rating to a “conviction-buy” rating in a research note on Monday, July 14th. One research analyst has rated the stock with a sell rating, eight have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $70.40.

Endo International PLC, formerly Endo Health Solutions Inc, is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.